Atlas Trials

A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

Clinical trial NCT04614467 · TERMINATED

Trial details

NCT number
NCT04614467
Sponsor
Lisata Therapeutics, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Coronary Microvascular DysfunctionCoronary Microvascular DiseaseMicrovascular Coronary Artery Disease
Start date
2020-10-29
Primary completion
2022-09-28
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.